Agilent Technologies (NYSE:A) Updates Q2 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its second quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.250-1.280 for the period, compared to the consensus earnings per share estimate of 1.310. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Trading Up 0.2 %

Shares of A traded up $0.33 during trading on Wednesday, reaching $134.51. 1,538,129 shares of the company traded hands, compared to its average volume of 1,675,135. The stock has a 50-day simple moving average of $140.87 and a 200-day simple moving average of $139.31. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. Agilent Technologies has a twelve month low of $124.16 and a twelve month high of $155.35. The stock has a market cap of $38.37 billion, a PE ratio of 30.43, a price-to-earnings-growth ratio of 3.66 and a beta of 1.07.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. On average, analysts anticipate that Agilent Technologies will post 5.56 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on A shares. JPMorgan Chase & Co. lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Citigroup upped their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $135.00 to $145.00 in a report on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $144.38.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.